Table 4. Top TAOK3 SNPs associated with maximum postoperative pain ≥ 7/10 in children of European Caucasian and African-American ancestry.
EC discovery cohort (n=277) | AA discovery cohort (n=241) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP | Gene | Minor/Major allele | MAF (cases) | MAF (controls) | OR | CI 95% | P-value | MAF (cases) | MAF (controls) | OR | CI 95% | P-value |
rs795484 | TAOK3 | A/G | 0.42 | 0.25 | 2.35 | (1.56, 3.52) | 4.10x10-5 | 0.32 | 0.21 | 1.76 | (1.14, 2.71) | 9.69×10-3 |
rs1277441 | TAOK3 | C/T | 0.42 | 0.26 | 2.24 | (1.49, 3.36) | 1.03x10-4 | 0.34 | 0.23 | 1.71 | (1.12, 2.61) | 1.21×10-2 |
Relationship of GWAS-identified top TAOK3 SNPs for primary outcome of morphine dose with secondary outcome of high maximum pain scores. There were 132 cases with high maximum pain score ≥7 and 136 controls with maximum pain score <7 in the EC discovery cohort; 103 cases and 118 controls in the AA discovery cohort. AA = African-American, CI 95%= 95% confidence interval, EC = European Caucasian; GWAS = genome-wide association study, MAF = minor allele frequency, OR = odds ratio, SNP = single nucleotide polymorphism.